Elgemtumab (LJM716) is a fully humanised monoclonal antibody targeting HER3/ERBB3, acting as an antagonist to block HER3/Akt phosphorylation and exhibiting antitumour activity.
Purity:
96.10%
CAS Number:
[1512559-37-3]
Target:
HER|||EGFR
* VAT and and shipping costs not included. Errors and price changes excepted